Private employers added 145,000 jobs and annual pay jumped 6.9 percent in March, according to a monthly report from payroll processing firm ADP. That is down from 261,000 in February and below estimates of 210,000.
“Our March payroll data is one of several signals that the economy is slowing,” said Nela Richardson, chief economist, ADP. “Employers are pulling back from a year of strong hiring and pay growth, after a three-month plateau, is inching down.”
The report comes one day after a federal report showed job openings falling below 10 million for the first time in two years, when a historically tight labor market left employers struggling to fill positions.
Some of the biggest job gains were in resources and mining, which added 47,000 jobs, and trade, transportation, and utilities, which added 56,000 jobs. Professional and business services, meanwhile, shed 46,000 jobs, and financial services lost 51,000.
Annual pay growth for job stayers also fell from 7.2 percent to 6.9 percent, which remains historically high, while pay growth for job changers fell from 14.4 percent to 14.2 percent.
Joe Spector, founder of Dutch and Hims & Hers co-founder, joins us to discuss how telehealth is transforming pet care—and what’s next for modern vet medicine.
Exclusive: Behr’s Andy Lopez reveals how ChatHUE, a bold collaboration with Google, is using AI to transform how we explore, choose, and connect with color.
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older pati